PharmaTimes December 13, 2023
Jen Brogan

In England, ruptured brain aneurysms occur in around one in 15,000 people every year

Researchers from King’s College London’s (KCL) School of Biomedical Engineering and Imaging Sciences have confirmed the safety of a new flow-diverting stent device to prevent blood flow into brain aneurysms.

Published in the Journal of Neurointerventional Surgery, the study assessed the safety of the updated Pipeline Vantage Embolization Devices (PEDV) to treat the condition.

In England, every year, around one in 15,000 people have a ruptured brain aneurysm, a bulge in a blood vessel in the brain that can cause headaches, changes to vision and severe headaches if it ruptures.

The risk of an aneurysm rupture heightens when blood pressure in the blood vessels rises, causing...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Provider, Survey / Study, Trends
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article